Comparar métodos
Examine os métodos selecionados lado a lado; as linhas que diferem ficam destacadas.
| cDLQI× | POEM (Medida de Eczema Orientada ao Paciente)× | |
|---|---|---|
| Área | Dermatologia | Dermatologia |
| Família | Process / pipeline | Process / pipeline |
| Ano de origem≠ | 1995 | 2004 |
| Autor original≠ | Lewis-Jones MS, Finlay AY | Charman CR, Venn AJ, Williams HC |
| Tipo≠ | Self-report (parent or child proxy) | Self-report |
| Fonte seminal≠ | Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (cDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-949. DOI ↗ | Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol. 2004;140(12):1513-1519. DOI ↗ |
| Outros nomes≠ | cDLQI, Pediatric DLQI | POEM Score |
| Relacionados≠ | 3 | 2 |
| Resumo≠ | The Children's Dermatology Life Quality Index (cDLQI) is a pediatric-adapted version of the adult DLQI, measuring the impact of skin disease on quality of life in children and adolescents aged 4–16 years. Developed by Lewis-Jones and Finlay in 1995, it uses child-friendly language and addresses domains relevant to childhood (school, leisure, friendships, clothing) rather than work and adult relationships. cDLQI is the standard quality-of-life measure in pediatric dermatology trials and clinical practice. | The POEM is a brief, patient-administered severity measure for atopic dermatitis that focuses on frequency of symptoms experienced over the past week. Developed by Charman, Venn, and Williams in 2004, it emphasizes the patient's lived experience rather than clinician observation, making it practical for routine clinical practice and remote monitoring. POEM is increasingly used alongside objective measures in clinical trials and outpatient care. |
| ScholarGateConjunto de dados ↗ |
|
|